Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity.

Retinopathy of prematurity: Past, present and future. World J Clin Pediatr (2016) 0.83

Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol (2016) 0.76

The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol (2005) 10.63

Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr (1969) 6.20

New Ballard Score, expanded to include extremely premature infants. J Pediatr (1991) 5.82

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35

Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol (2006) 2.23

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A (2007) 1.88

Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol (2009) 1.39

IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab (2002) 1.29

Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates. Nutrition (2002) 1.13

Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol (2004) 1.03

Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod (1998) 1.02

Cumulative illness severity and progression from moderate to severe retinopathy of prematurity. J Perinatol (2007) 1.02

The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res (2005) 1.01

IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab (2002) 0.94

Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. J Clin Endocrinol Metab (1997) 0.93

Effects of early amino acid administration on leucine and glucose kinetics in premature infants. Pediatr Res (2006) 0.91

Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants. Pediatr Int (2012) 0.91

Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum. Pediatr Res (1994) 0.90

Incidence of retinopathy of prematurity and risk factors in the South-Western region of iran. Middle East Afr J Ophthalmol (2012) 0.87

Incidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey. Turk J Pediatr (2012) 0.84

Changes in the circulating form of serum somatomedin-C during fetal life. J Clin Endocrinol Metab (1980) 0.82

Aggressive nutrition for preterm infants--benefits and risks. Early Hum Dev (2007) 0.79

Early aggressive nutrition for the premature infant. Neonatology (2008) 0.78

Nutritionally regulated hormonal factors in prolonged postnatal growth retardation and its associated adverse neurodevelopmental outcome in extreme prematurity. Biol Neonate (2003) 0.78